Israel Englander Crispr Therapeutics Ag Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Millennium Management LLC holds 26,326 shares of CRSP stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,326

Previous 3,100 749.23%

Holding current value

$1.34 Million

Previous $211,000 573.46%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $4.06 Million - $5.41 Million	-79,317 Reduced 75.08%	26,326 $1.42 Million
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $5.36 Million - $7.88 Million	88,373 Added 511.71%	105,643 $7.2 Million
Q4 2023 Feb 14, 2024	SELL	$38.62 - $72.18 $1.74 Million - $3.25 Million	-44,977 Reduced 72.26%	17,270 $1.08 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $7.29 Million - $11.4 Million	-167,730 Reduced 72.93%	62,247 $3.49 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $8.93 Million - $12.2 Million	217,833 Added 1793.75%	229,977 $10.4 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $99,268 - $166,342	2,533 Added 26.36%	12,144 $494,000
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $587,232 - $805,209	9,611 New	9,611 $628,000
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $18.1 Million - $26.9 Million	-340,078 Reduced 88.13%	45,788 $2.87 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $13.6 Million - $21.6 Million	194,166 Added 101.29%	385,866 $29.2 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $10.9 Million - $15.5 Million	99,061 Added 106.93%	191,700 $21.5 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $1.06 Million - $1.7 Million	-10,473 Reduced 10.16%	92,639 $15 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $8.96 Million - $17 Million	80,927 Added 364.78%	103,112 $12.6 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $1.77 Million - $3.84 Million	22,185 New	22,185 $3.4 Million
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $1.62 Million - $2.07 Million	-20,592 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $792,792 - $1.57 Million	20,592 New	20,592 $1.51 Million
Q1 2020 May 14, 2020	SELL	$33.68 - $62.53 $10.5 Million - $19.5 Million	-312,433 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $7.55 Million - $15.1 Million	205,895 Added 193.26%	312,433 $19 Million
Q3 2019 Nov 14, 2019	BUY	$40.99 - $52.56 $4.37 Million - $5.6 Million	106,538 New	106,538 $4.37 Million
Q4 2018 Feb 14, 2019	SELL	$22.73 - $42.34 $1.53 Million - $2.84 Million	-67,179 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $2.98 Million - $4.41 Million	67,179 New	67,179 $2.98 Million
Q1 2018 May 15, 2018	SELL	$23.52 - $58.17 $2.24 Million - $5.53 Million	-95,130 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$16.95 - $23.48 $336,593 - $466,265	19,858 Added 26.38%	95,130 $2.23 Million
Q3 2017 Nov 14, 2017	BUY	$16.75 - $20.66 $1.26 Million - $1.56 Million	75,272	75,272 $1.35 Million

Others Institutions Holding CRSP

# of Institutions

503

Shares Held

57.1M

Call Options Held

1.74M

Put Options Held

1.83M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.96B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account